aurintricarboxylic acid has been researched along with gentian violet in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| de Castro, SL; Pinto, AV; Pinto, MC | 1 |
2 other study(ies) available for aurintricarboxylic acid and gentian violet
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Screening of natural and synthetic drugs against Trypanosoma cruzi. 1. Establishing a structure/activity relationship.
Topics: Animals; Anthraquinones; Aurintricarboxylic Acid; Benzhydryl Compounds; Coloring Agents; Drug Evaluation, Preclinical; Gentian Violet; Hematoxylin; Lectins; Naphthols; Phenolphthaleins; Picrates; Structure-Activity Relationship; Strychnine; Trypanocidal Agents; Trypanosoma cruzi | 1994 |